Strattera
In brief
- Strattera (atomoxetine) is a prescription-only medicine in the UK and should be supplied only with a valid prescription.
- Strattera is used for the treatment of attention deficit hyperactivity disorder (ADHD). It is a non-stimulant selective noradrenaline reuptake inhibitor, which helps improve attention, impulse control and hyperactivity.
- The usual dose depends on age and body weight: in children and adolescents, treatment often starts at about 0.5 mg/kg/day and is increased after at least 7 days to around 1.2 mg/kg/day, with a maximum of 1.8 mg/kg/day (100 mg per day for body weight 70 kg and above); in adults, the initial dose is usually 40 mg/day, increasing to a target of about 80 mg/day, with a maximum of 100 mg/day.
- Strattera is taken by mouth as capsules, usually once daily in the morning, or sometimes split into morning and late afternoon/evening doses.
- It does not work immediately; some improvement may be noticed within 1–2 weeks, but the full effect often takes several weeks of regular use.
- The duration of action is about 24 hours, which is why it is typically taken once daily.
- Alcohol is not recommended, as it may worsen dizziness, drowsiness and other side effects and can make it harder to monitor your response to treatment.
- The most common side effects are decreased appetite, dry mouth, nausea, upset stomach, fatigue, drowsiness, dizziness, headache and sleep disturbances.
- Would you like to try Strattera without a prescription?
Legal status and availability in the UK
Strattera (atomoxetine) is a prescription-only medicine (POM) in the UK.
In our online pharmacy, Strattera is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.
Basic Strattera information
- INN (international nonproprietary name): atomoxetine
- Brand names available in the United Kingdom: Strattera, generic atomoxetine
- ATC code: N06BA09
- Forms & dosages: Capsules in 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, and 100 mg strengths
- Manufacturers in the United Kingdom: Eli Lilly and multiple generic manufacturers
- Registration status in the United Kingdom: Prescription only (Rx)
- OTC / Rx classification: Prescription only (Rx)
Strattera is the best-known brand name for atomoxetine in the UK.
The active ingredient is atomoxetine, and the medicine sits in the ADHD treatment family rather than the stimulant family.
It is supplied in capsule form, with blister-pack packaging being the common format patients recognise in UK pharmacies.
Generic atomoxetine is widely available after patent expiry, so patients may receive a generic version instead of the branded product.
The label may change between pharmacies, but the active ingredient remains atomoxetine and the indication remains ADHD.
Clinical effectiveness in the United Kingdom NHS context
Does Strattera actually help in day-to-day life, or only on paper in trials?
That is the question most patients ask once the prescription is in hand.
In routine NHS care, atomoxetine tends to be judged less by dramatic early changes and more by gradual improvements in focus, impulsivity, emotional regulation, and the ability to stay on task at school or work.
Patients may also notice fewer arguments, less interrupting, or an easier time finishing forms, homework, or office tasks.
What can be disappointing early on is the lack of a quick switch-on effect.
Unlike stimulants, the benefit of Strattera usually builds slowly, which is why a trial of at least 4–6 weeks is commonly needed before judging response properly.
Adults are often told to expect a target dose around 80 mg daily, with long-term review once the dose is stable.
In UK practice, that review matters because the medicine may be continued only if it is clearly helping function, not just symptoms on a checklist.
What improvement often looks like
Better concentration for longer periods.
Fewer missed deadlines or lost school tasks.
Less emotional reactivity during the day.
More predictable routines and less chaos around mornings or homework.
What can be disappointing early on
No obvious change in the first few days.
Nausea, tiredness, or reduced appetite before benefit appears.
Feeling that it is “too gentle” compared with stimulant treatment.
Thinking it is not working before enough time has passed.
NHS shared-care arrangements usually mean that specialist ADHD clinics or initiation teams start the medicine and then involve the GP for ongoing supply once the patient is stable.
Pharmacists play a practical part here by checking the dose, spotting interactions, and helping patients tell whether atomoxetine treatment is worth continuing.
Patient-reported benefit is often strongest when the expectation is realistic: steady improvement over weeks, not a same-day change.
That is why people who cannot tolerate stimulants, or who need a lower misuse risk option, may do better with atomoxetine even if the onset is slower.
Indications and expanded uses
Is atomoxetine a general focus booster, or is it really just for ADHD?
- Licensed use
- ADHD in children aged 6 years and above, adolescents, and adults.
- Common NHS use
- Chosen when stimulants are contraindicated, ineffective, poorly tolerated, or when diversion risk is a concern.
- Off-label interest
- Atomoxetine remains primarily an ADHD medicine rather than a general “focus enhancer”.
In the UK, the key point is straightforward: Strattera capsules are approved for ADHD, and that is the main condition for which clinicians should think about them.
Because atomoxetine is not a controlled substance, it can be attractive in situations where stimulant prescribing is not ideal.
That includes patients with a history of misuse, people worried about dependency, and those who previously stopped stimulants because of side effects.
It is also relevant where a non-stimulant ADHD medication fits better with the patient’s daily life, work pattern, or mental health history.
In the UK, Strattera is a prescription-only medicine and should be supplied through lawful prescribing and pharmacy checks.
Composition, brand names and United Kingdom packaging landscape
Can patients recognise Strattera by the capsule colour alone?
Sometimes they think they can, but UK advice is to trust the pharmacy label rather than the colour on memory.
The active ingredient is atomoxetine, with Strattera as the brand name most people know.
Generic atomoxetine is also common, so the box may look different even when the medicine is the same.
Capsules are typically blister-packed, and because generic substitution is common, two patients taking the same dose can end up with different-looking packs.
For UK patients, the safest habit is simple: check the name, strength, and directions on the label every time.
Contraindications and special precautions
Who should not take atomoxetine, and who needs extra care?
| Do not use | Use with caution and monitor closely |
|---|---|
| Hypersensitivity to atomoxetine or any capsule component | Hypertension or tachycardia |
| Narrow-angle glaucoma | History of seizures or seizure disorders |
| MAO inhibitor use within the last 14 days | Psychiatric comorbidity, including depression and suicidal ideation in young people |
| Severe cardiovascular disorders, such as severe hypertension or tachyarrhythmias | Hepatic impairment |
Atomoxetine safety is especially important in the first months, because mood changes, palpitations, or blood pressure changes need to be reported promptly.
Young people should be monitored carefully because of the risk of increased suicidal ideation in children and adolescents.
Data for older adults are limited, so caution is sensible where comorbidities are already present.
Children under 6 years have not been studied, so treatment is not recommended in that age group.
UK advice about driving, alcohol, and routine safety still applies.
If the medicine causes dizziness, drowsiness, or blurred concentration, driving or operating machinery should be reconsidered until the effect is clear.
Alcohol may worsen tiredness or poor judgement, and any palpitations, mood shifts, or urinary retention should be reported quickly.
Dosage guidelines
How is atomoxetine usually started in UK-style practice?
The schedule is usually gradual, which helps with tolerability and makes side effects easier to judge.
| Age group | Starting dose | Target dose | Maximum dose |
|---|---|---|---|
| Children and adolescents | About 0.5 mg/kg/day | About 1.2 mg/kg/day after a minimum of 7 days | 1.8 mg/kg/day (100 mg/day for body weight 70 kg and above) |
| Adults | 40 mg/day | 80 mg/day | 100 mg/day |
Adults may take the dose once daily in the morning, or split it into morning and late afternoon/evening depending on tolerability and the prescriber’s plan.
The medicine is usually reviewed over a long-term regimen rather than a short burst, with response and side effects checked regularly.
Liver impairment needs particular dose adjustment: moderate impairment usually means half the usual dose, and severe impairment usually means one-quarter.
Mild or moderate kidney impairment usually does not need adjustment, but severe impairment still needs caution.
Under-6s are not recommended, and the elderly require careful clinical judgement because data are limited.
The exact dose should follow the prescription rather than the capsule colour.
Interactions overview
What medicines, drinks, or habits can get in the way of atomoxetine?
| Avoid | Use caution | Generally manageable |
|---|---|---|
| MAO inhibitors | Medicines that can raise heart rate or blood pressure | Food intake, as atomoxetine is not usually a “take with food” medicine |
| Recent MAOI use within 14 days | Cardiovascular medicines that affect pulse or pressure | Tea and coffee in normal amounts, unless they worsen jitteriness or sleep |
| — | Alcohol, especially if tiredness or dizziness occurs | Missed-dose behaviour, if followed correctly |
Nausea can make people stop taking atomoxetine, so pharmacists often ask about timing, appetite, and whether a dose is being taken at the same time each day.
That review is worth doing with all prescription and over-the-counter products, because interaction risk is not limited to the obvious ADHD medicine list.
If an unexpected reaction happens, the MHRA Yellow Card system is the right route for reporting.
A quick pharmacy conversation can prevent a small issue, such as an interaction with a blood pressure medicine or sleep trouble after late caffeine, from becoming the reason the medicine is abandoned.
Comparable medicines and patient preferences
How does Strattera compare with the better-known ADHD medicines?
| Medicine | Class | Onset | Abuse potential | Likely NHS use |
|---|---|---|---|---|
| Ritalin | Methylphenidate stimulant | Usually faster | Higher than atomoxetine | Common ADHD option |
| Concerta | Methylphenidate extended release stimulant | Usually faster | Higher than atomoxetine | Common ADHD option |
| Elvanse | Lisdexamfetamine prodrug stimulant | Usually faster | Higher than atomoxetine | Used in ADHD treatment |
| Intuniv | Guanfacine non-stimulant | Slower | Low | Specialist ADHD use |
Why choose atomoxetine over a stimulant?
The main reasons are the non-stimulant profile, the lower abuse potential, and suitability where stimulant side effects, intolerance, or diversion risk make them less attractive.
Why do some patients switch away?
Slow onset, stomach upset, sleep disturbance, or an incomplete response can push people back towards another ADHD Rx after a proper review.
Shared decision-making is a big part of UK ADHD treatment, because the best medicine is the one a patient can actually take consistently.
Frequently asked questions
- How long does Strattera take to work?
- Most people need at least 4–6 weeks before the benefit can be judged properly, and the response may keep improving after that.
- Can I drink alcohol or coffee?
- Small amounts are often manageable, but alcohol can worsen drowsiness or dizziness, and too much coffee may aggravate jitteriness or sleep problems.
- What if I miss a dose?
- Take it as soon as remembered, unless the next dose is near; in that case skip it and do not double dose.
- Is atomoxetine addictive?
- Atomoxetine is not a controlled substance and does not have the same abuse profile as stimulant ADHD medicines.
If unusual symptoms appear after a missed dose, an accidental extra dose, or a new side effect, the pharmacist, GP, or NHS 111 should be the first contact.
Overdose symptoms can include somnolence, hyperactivity, stomach upset, and abnormal behaviour, and urgent medical attention is needed.
Guidelines for proper use
What does good day-to-day use look like in a UK pharmacy setting?
- Take atomoxetine at the same time each day.
- Swallow the capsules whole.
- Do not double a dose after a missed one.
- Watch for mood change, palpitations, appetite loss, or worsening sleep.
- Keep follow-up appointments so benefit and tolerability can be reviewed.
- Store the capsules away from moisture and light, in the original packaging.
- Keep the medicine out of reach of children.
Pharmacists often focus on appetite, sleep, blood pressure, mood, and adherence because those are the practical markers that show whether treatment is helping.
If the patient is struggling, the ADHD clinic or GP surgery can adjust the plan, and NHS patient portals can help with repeat requests and results.
With atomoxetine, the key is consistency and monitoring rather than expecting a quick burst of effect.
Delivery across the United Kingdom
| City | Region | Delivery time |
|---|---|---|
| London | England | 9–21 days |
| Birmingham | England | 9–21 days |
| Manchester | England | 9–21 days |
| Leeds | England | 9–21 days |
| Liverpool | England | 9–21 days |
| Glasgow | Scotland | 9–21 days |
| Edinburgh | Scotland | 9–21 days |
| Cardiff | Wales | 9–21 days |
| Belfast | Northern Ireland | 9–21 days |
| Sheffield | England | 9–21 days |
| Bristol | England | 9–21 days |
| Newcastle upon Tyne | England | 9–21 days |
| Nottingham | England | 9–21 days |
| Leicester | England | 9–21 days |
For a medicine like Strattera, delivery timing matters because repeat supply and uninterrupted use are often part of stable ADHD control.
